Citation tools

Lim, Ven G. et al "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart." JACC: Basic to Translational Science (2019): 264. Web. 16 Feb. 2019.
Advertisement